REFILE-Germany’s BioNTech lowers price for U.S. IPO amid market volatility
German biotechnology firm BioNTech SE
lowered the price range for its U.S. initial public
offering (IPO) on Wednesday and said it would sell fewer shares,
making it the latest company to struggle to debut in the stock
market.
lowered the price range for its U.S. initial public
offering (IPO) on Wednesday and said it would sell fewer shares,
making it the latest company to struggle to debut in the stock
market.
Posted by Reuters
